Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
McKesson
Citi
Express Scripts
Mallinckrodt
Harvard Business School
Merck
Teva
Healthtrust

Generated: February 25, 2018

DrugPatentWatch Database Preview

DECABID Drug Profile

« Back to Dashboard

Which patents cover Decabid, and what generic alternatives are available?

Decabid is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in DECABID is indecainide hydrochloride. Additional details are available on the indecainide hydrochloride profile page.
Summary for DECABID
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 4
Patent Applications: 130
Drug Prices:see details
DailyMed Link:DECABID at DailyMed
Drug patent expirations by year for DECABID

US Patents and Regulatory Information for DECABID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DECABID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cipla
Mallinckrodt
McKinsey
Chinese Patent Office
Moodys
US Army
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot